SCHEMBL7571198

SCHEMBL7571198

NCC#Cc1ccco1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31367857 0.84 ALOX5 (0.39)
SCHEMBL16345466 0.78
SCHEMBL9906388 0.78
SCHEMBL16345143 0.78
SCHEMBL1799185 0.78 ALOX5 (0.43)
SCHEMBL6643512 0.75 ALOX5 (0.37)
SCHEMBL13626441 0.75 ALOX5 (0.37)
SCHEMBL11272511 0.75 RAB9A (0.40)
SCHEMBL6240281 0.75 ALOX5 (0.48)
SCHEMBL5517928 0.74 ALOX5 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240425517-A1 NOVEL COMPOUND FOR DEGRADATION OF TARGET PROTEIN OR POLYPEPTIDE BY POLYUBIQUITINATION PRAZER THERAPEUTICS INC. (KR) 2024-12-26 US claimed
US-20240425517-A1 NOVEL COMPOUND FOR DEGRADATION OF TARGET PROTEIN OR POLYPEPTIDE BY POLYUBIQUITINATION PRAZER THERAPEUTICS INC. (KR) 2024-12-26 US disclosed
CN-118382620-A Novel compounds for degrading target proteins or polypeptides by multiple ubiquitination 普瑞泽治疗公司 2024-07-23 CN disclosed
EP-0810199-B1 Method for producing propargylamine compounds SUMITOMO CHEMICAL CO (JP) 2002-09-25 EP disclosed
US-5756769-A Method for producing propargylamine compounds SUMITOMO CHEMICAL COMPANY, LTD. (JP) 1998-05-26 US disclosed
EP-0810199-A1 Method for producing propargylamine compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1997-12-03 EP disclosed
EP-0281018-A1 Heterocyclyl-2-propyn-1-amines MERRELL DOW PHARMACEUTICALS INC. (US) 1988-09-07 EP disclosed
US-4743617-A HYPOTENSIVES MERRELL DOW PHARMACEUTICALS INC. (US) 1988-05-10 US disclosed